Fever, cancer incidence and spontaneous remissions

NeuroImmunoModulation

Volumn 9, Issue 2, 2001, Pages 55-64

  Kleef, Ralf ^a,d   Jonas, Wayne B ^b   Knogler, Wolfgang ^c   Stenzinger, Werner ^d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Menox Ambulatorien   (Austria)

^d Odenwaldklinik ^*  (Austria)

Author keywords

Cancer incidence; Epidemiology; Fever; Immunology; Spontaneous remissions

Indexed keywords

ALPHA INTERFERON; COLONY STIMULATING FACTOR; CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; BONE TUMOR; CANCER; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER REGRESSION; CANCER RISK; CHILD; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; REMISSION; REVIEW;

COMMUNICABLE DISEASES; FEVER; HUMANS; INCIDENCE; NEOPLASMS; NEUROIMMUNOMODULATION; REMISSION, SPONTANEOUS;

EID: 0034837504     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049008     Document Type: Review

References (217)

1. Enhanced antibody response in retrovirus-infected mice treated with endotoxin or nontoxic polysaccharide derivative
2. Distinctive immunomodulatory effects of endotoxin and nontoxic lipopolysaccharide derivatives in lymphoid cell cultures
3. Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis
4. Long-term effects of treatment of childhood malignancy
5. Late effects of adjuvant therapy for breast cancer
6. Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease
7. Long-term toxicity of tamoxifen
8. Bladder neoplasm in a patient with panarteritis nodosa treated with cyclophosphamide
9. Long-term effects of adjuvant chemotherapy in breast cancer
10. Effects of adjuvant chemotherapy on specific and non-specific immune mechanisms
11. Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy
12. Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy
13. Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer
14. Effects of chemotherapeutic agents on the immune response. II
15. The increase in immunosuppression and its role in the development of malignant lesions
16. Have we reduced the risk of getting cancer or of dying from cancer? An update
17. Cancer undefeated
18. Chemotherapy of advanced epithelial cancer - A critical review
19. Shifting the cancer paradigm: Must we kill to cure?
20. A new biological framework for cancer research
21. The war on cancer
22. Treatment of inoperable malignant tumors with toxins of erysipelas and the Bacillus prodigiosus
23. Inoperable sarcoma: A further report of cases successfully treated with the mixed bacterial toxins of erysipelas and Bacillus prodigiosus
24. Further observations upon the treatment of malignant tumors with the toxins of erysipelas and Bacillus prodigiosus with a report of 160 cases
25. A report of recent cases of inoperable sarcomas successfully treated with mixed toxines of erysipelas andBacillus prodigiosus
26. Endothelioma myeloma of tibia: Long-standing cure by toxin treatment
27. The therapeutic value of the mixed toxins of the streptococcus of erysipelas and Bacillus prodigiosus in the treatment of inoperable malignant tumors. With a report of 160 cases
28. The treatment of inoperable sarcoma by bacterial toxines (the mixed toxines of the streptococcus of erysipelas and the Bacillus prodigiosus)
29. The treatment of malignant tumors by repeated inoculations of erysipelas: With a report of ten original cases
30. Primary malignant tumors of the long bones
31. Coley's toxins, tumor necrosis factor and cancer research: A historical perspective
32. A superantigen-antibody fusion protein for T cell immunotherapy of human B-lineage malignancies
33. Genetically engineered superantigens as tolerable antitumor agents
34. Immunological effects of BCG in malignant melanoma: Two modes of administration compared
35. Mechanism of action of BCG vaccine on neoplastic proliferation and host immune responses
36. Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guerin (BCG) immunotherapy
37. Production of urinary tumour necrosis factors and soluble tumour necrosis factor receptors in bladder cancer patients after bacillus Calmette-Guerin immunotherapy
38. Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guerin (BCG) instillation on carcinoma in situ of the urinary bladder
39. Clinical and histologic correlation of melanoma regression after intralesional BCG therapy: A case report
40. From the 19th to the 21st centuries: BCG in the treatment of superficial bladder cancer
41. Krebs und Infektionskrankheiten
42. Über den Infektionsindex der Krebskranken
43. Über den Einfluss des Alters auf den Infektionsindex der Krebskranken
44. Versuch einer statistischen Erfassung endogener Faktoren bei Carcinomerkrankungen
45. Anamnese und Zweiterkrankungen bei Patienten mit bösartigen Neubildungen
46. A case control study of carcinoma of the ovary
47. Tumorträger haben selten Infekte in der Anamnese
48. Environmental factors in the etiology of rhabdomyosarcoma in childhood
49. Measles virus infection without rash in children is related to disease in adult life
50. Childhood leukemia and infectious diseases in the first year of life: A register based case-control study
51. The common cold, allergy, and cancer
52. Incidence of infection and cancer risk
53. Cancer occurrence from the biometric viewpoint
54. Common infections in the history of cancer patients and controls
55. Medical risk factors and development of brain tumors
56. Reported herpes-virus-infection, fever and cancer incidence in a prospective study
57. Melanom und Atopie
58. Febrile infections and malignant melanoma: Results of a case-control study
59. Risk of adult acute leukemia in relation to prior immune-related conditions
60. Carcinoma of the lung after heart transplantation
61. Transplant immunosuppression-related malignant lymphomas
62. Lymphoma risks in populations with altered immunity - A search for mechanism
63. B-cell lymphoma in organ transplant recipients
64. Carcinoma of the urinary bladder in a patient receiving cyclophosphamide for Wegener's granuloma: A case report
65. Review article: The risks of malignancy from either immunosuppression or diagnostic radiation in inflammatory bowel disease
66. General overview of studies of multigeneration carcinogenesis in man, particularly in relation to exposure to chemicals
67. Cancers after cyclosporine therapy
68. Posttransplant malignancies in pediatric organ transplant recipients
69. Malignancy
70. Malignancies after liver transplantation: A comparative review
71. Fever: Its history, cause and function
72. Fever: Role of pyrogens and cryogens
73. The immunological consequences of fever
74. Impact of temperature elevation on immunologic defenses
75. Endogenous pyrogens
76. Thermoregulation and the pathogenesis of fever
77. The concept of immunological surveillance
78. Implications of immunological surveillance for cancer therapy
79. Bacterial vaccine therapy of cancer
80. Bacterial Products in the Treatment of Cancer: Past, Present and Future (meeting paper)
81. Bacterial pyrogens: Beneficial effects on cancer patients
82. Immuntherapie des Krebses
83. Bacteria and cancer - Antagonisms and benefits
84. Historical perspective on the development of inbred mice. Introductory remarks
85. Coley toxins - The first century
86. Treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research
87. A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man
88. Antitumor effects of endotoxins
89. Fluctuations in the growth energy of malignant tumors in man, with especial reference to spontaneous regression
90. Über den heilenden Einfluss des Erysipels auf Gewebsneubildungen, insbesondere bösartige Tumoren
91. Spontaneous regression of cancer
92. Spontaneous regression of cancer
93. Spontaneous regression of cancer: Preliminary report
94. Spontaneous Regression of Cancer
95. Host immunity and spontaneous regression of cancer evaluated by computerized data reduction study
96. Spontaneous regression of reticulum-cell sarcoma of bone
97. Spontaneous regression of cancer and the importance of finding its cause
98. Efforts to explain spontaneous regression of cancer
99. The influence of complicating diseases upon leukemia
100. Effects of concurrent infections and their toxins on the course of leukemia
101. Spontaneous remission in hypoplastic acute leukemia
102. Die Rolle der bakteriellen Infektionen bei der Spontanremission maligner Tumoren und Leukosen
103. Effect of postoperative empyema on survival of patients with bronchogenic carcinoma
104. Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment
105. Tonsillectomy and leukemia in adults (author's translation)
106. Microorganisms as antineoplastic agents in CNS tumors
107. The strongest prognostic factors in colorectal carcinoma. Surgicopathologic stage of disease and postoperative fever
108. Are postoperative fever and/or septic complications prognostic factors in colorectal cancer resected for cure?
109. Beneficial effects of post-transfusional hepatitis in acute myelogenous leukemia may be mediated by lipopolysaccharides, tumor necrosis factor α and interferon γ
110. Psychoneuroendocrine immunology: Site of recognition, learning and memory in the immune system and the brain
111. Neural and humoral pathways of communication from the immune system to the brain: Parallel or convergent?
112. Cytokines and the related neurotransmitters in brain-immune interactions
113. Cytokines and fever
114. Fever and the immune response. The effects of physiological temperatures on primary murine splenic T cell responses in vitro
115. Temperature: A critical factor determining localization and natural history of infectious, metabolic, and immunological diseases
116. Temperature sensitivity of interleukin-dependent murine T cell proliferation: Q2 mapping of the responses of peanut agglutinin-negative thymocytes
117. Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis
118. Mechanism of synergistic cytotoxic effect between tumor necrosis factor and hyperthermia
119. Hyperthermia and human leukocyte functions: Effects on response of lymphocytes to mitogen and antigen and bactericidal capacity of monocytes and neutrophils
120. Effects of human interleukin-1 on natural killer cell activity: Is fever a host defense mechanism for tumor killing?
121. Inhibitory effects of elevated temperature on human cytokine production and natural killer activity
122. Antibody neutralization of picornaviruses: Can fever help?
123. Natural immunity and neuroimmune host defense
124. Multiple mechanisms mediate antipyretic action of glucocorticoids
125. Neurohormonal host defense in endotoxin shock
126. Spontaneous regression (cure?) of a malignant tumor of bone
127. Spontaneous resolution of an osteochondroma
128. Spontaneous regression of osteochondromas. Two case reports
129. Benign osteoblastoma of the mandible: Fifteen year follow-up showing spontaneous regression after biopsy
130. Benign osteoblastoma of the spine. Apropos of 4 cases with a case of spontaneous recovery
131. Regression of Burkitt's lymphoma in association with measles infection
132. Spontaneous regression of malignant disease: Report of three cases
133. Spontaneous involution of an intra-axial brain stem lesion: A case report
134. Spontaneous tumor regression in a patient with metastatic gastric cancer. Communication of an additional case
135. Spontaneous tumor regression and gastric cancer
136. Reversible vulvar atypia. A case report
137. Spontaneous remission of breast cancer. A literature review
138. Spontaneous remission of breast cancer
139. Complete regression of 2 non-operated hypopharyngeal carcinomas
140. The influence of immunologic responsiveness on head and neck cancer. Therapeutic implications
141. Spontaneous regression of hepatocellular carcinoma
142. Spontaneous regression of hepatocellular carcinoma
143. Spontaneous regression of hepatocellular carcinoma
144. Spontaneous necrosis of liver cancer: One more possible cause
145. Les remissions de la leucemie aigue
146. Multiple spontaneous remissions in a child with acute leukemia. The occurrence of agranulocytosis and aplastic anemia in acute leukemia and their relationship to remissions
147. Due casi di leucemia migliorati a seguito di complicazioni infettive
148. A case of prolonged spontaneous remission in a patient with chronic lymphatic leukemia
149. Splenic aspiration in acute leukaemia
150. Septicaemia in acute leukaemia
151. Remission in acute drug-resistant leukemia complicated with steroid diabetes and severe infection
152. Spontaneous regression of hematologic cancers
153. Beneficial effect of hepatitis in patients with acute myelogenous leukemia
154. Hepatitis and leukemia
155. Posttransfusion hepatitis in acute myelogenous leukemia: Effect on survival
156. Indicators of cellular immunity and the incidence of infectious-inflammatory diseases during clinico-hematological remission in patients with acute leukemia
157. Complete spontaneous remission in acute myeloblastic leukemia
158. Remission of acute lymphoblastic leukemia of childhood following acute infectious disease. A case report
159. Spontaneous remission of four months' duration in hypoplastic leukemia with tetraploid chromosome after blood transfusions and infection
160. Spontaneous remission in chronic lymphatic leukemia
161. Spontaneous remission in acute myeloid leukaemia
162. Spontaneous remission in acute myeloid leukaemia: A role for endogenous production of tumour necrosis factor and interleukin-2?
163. A case of spontaneous remission in chronic B-cell leukemia with virus infection
164. A spontaneous remission of lymphoid blast crisis in chronic myelogenous leukaemia following blood transfusion and infection
165. Anaplastic lung cancer with metastases. Case report of a 15-year survival
166. A new case of spontaneous tumor regression
167. Immunoreactivity in lung cancer
168. Hodgkin's disease: Remissions after measles
169. Spontaneous remission in Burkitt's lymphoma
170. Spontaneous regression in non-Hodgkin's lymphoma
171. Improved remission rate and duration in nodular non-Hodgkin lymphoma (NNHL) with the use of mixed bacterial vaccine (MBV)
172. Combined modality therapy of advanced nodular lymphoma (NL): The role of nonspecific immunotherapy (MBV) as an important determinant of response and survival
173. Spontaneous remission in diffuse large cell lymphoma
174. Spontaneous regression in non-Hodgkin's lymphoma: Clinical and pathogenetic considerations
175. Prolonged spontaneous remission of case of malignant lymphoma
176. Spontaneous tumor regression. Report of 2 cases
177. Spontaneous regression in angiocentric T cell lymphoma
178. Metastasis of an adenocarcinoma of unknown origin to mediastinal lymph nodes, and transient regression
179. Spontaneous regression of primary cerebral lymphoma
180. Regression of metastatic melanoma
181. Bilateral black hypopyon in a patient with self-healing cutaneous malignant melanoma
182. Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanoma
183. The significance of inflammation and regression in melanoma
184. Regressing malignant melanoma
185. Herpetic viruses and spontaneous recovery in melanoma
186. Multiple myeloma: Report of a case showing unusual remission lasting two years following severe hepatitis
187. Spontaneous remission of a bony metastasis in prostatic adenocarcinoma
188. Spontaneous regression of genitourinary cancer - An update
189. A new case of spontaneous regression of metastasis of kidney cancer
190. Spontaneous regression of primary and metastatic renal cell carcinoma
191. Unexpected regressed retinoblastoma
192. Retinoblastoma undergoing spontaneous regression. Calcifying agent suggested in treatment of retinoblastoma
193. Retinoblastoma in phthisis bulbi
194. Spontaneous cure of congenital recurring connective tissue tumor
195. Spontaneous regression of a case of myosarcoma
196. The spontaneous cure of massive fibrosarcoma
197. Lymphosarcoma. Remission associated with viral hepatitis
198. Role of lymphocytes in spontaneous regression of experimentally transplanted canine transmissible venereal sarcoma
199. 'Spontaneous' regression of advanced leiomyosarcoma of the urinary bladder